Merck & Co., Inc. (MRK) Tops Q2 EPS by 4c
Tweet
Share
E-mailGet Alerts MRK Hot Sheet
Price: $134.58 +1.25%
Financial Fact:
Marketing and administrative: 7.32B
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Marketing and administrative: 7.32B
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Merck & Co., Inc. (NYSE: MRK) reported Q2 EPS of $1.05, $0.04 better than the analyst estimate of $1.01. Revenue for the quarter came in at $12.2 billion versus the consensus estimate of $12.16 billion.
For earnings history and earnings-related data on Merck & Co., Inc. (MRK) click here.
For earnings history and earnings-related data on Merck & Co., Inc. (MRK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jefferies sees a buying opportunity in this S&P 500 sector
- Tencent Holdings (700:HK) (TCEHY) PT Lowered to HK$625 at Benchmark to Reflect Downward Earnings Revisions
- Exclusive: BitGo says institutional conversations are shifting to tokenization
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
